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Introduction
Systemic Lupus Erythematous (SLE) is a chronic autoim-
mune disease characterized by multi-organ involvement.
Its pathogenesis remains controversial. Diagnosis in chil-
dren is also based on the ARA criteria (American Rheu-
matism Association).
Objectives
We propose to report the epidemiological, clinical, immu-
nological, therapeutic and evolutive profile of childhood’s
SLE through this retrospective study in the Pediatric
Rheumatology Service of the Children’s Hospital of Casa-
blanca, conducted between December 2001 and January
2014.
Methods
We report a series of 30 children, including 25 girls, mean
age of onset is 12 years, with a range of 7-16 years, the
average time from diagnosis is 6 months. The mode of
presentation of the disease is classical (general signs, skin
and joints involvement) in 56% of cases, by lupus nephritis
in 26.66 % of patients, or a Macrophage Activation Syn-
drome “MAS” in 13.33 % of cases and lupus nephritis
associated with MAS in one patient.
Results
The clinical picture showed fever in 76.66% of patients, the
frequency of joint locations (90%), skin (86.66%), kidney
(66.6%) , hematologic (50%) lung (36.66%), gastrointestinal
(30%), neuropsychiatric (26.66%) and cardiac (23.3%)
involvement.
The hematological involvement was detected in
76.66% of our patients, an inflammatory syndrome in
83.33%, immunological disturbances with positive titers
of anti- DNAN AC (90%) , ANA (93.6%), and a reduc-
tion of the complement (83.33%) . False syphilis serology
completed by anti b2Glycoprotein1 antibodies (26%) and
anti- cardiolopine were positive in respectively 40, 26
and 20% of cases. Renal involvement is manifested by
renal insufficiency in 43% of cases, a significant protei-
nuria in 50% of cases and prevalence of class IV on
biopsy. A case of kikushi fujimoto has been reported as
5 hemophagocytic syndromes.
All patients were treated with systemic corticosteroids
and hydroxychloroquine. The use of methylprednisolone
bolus was indicated in cases of SAM or severe renal
impairment associated with cyclophosphamide / MMF
and anti-proteinuric medication.
Conclusion
The prognosis of pediatric SLE remains unpredictable;
however it is attached to the renal, neurological and the
occurrence of MAS. We mourn two deaths one by neu-
rological attack and other by renal failure.
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